Skip to main content

and
  1. No Access

    Article

    Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas

    Psoriasis, a chronic inflammatory condition, often presents challenges in treatment, particularly in areas such as nails, palms/soles, scalp/face, and genitalia. Monoclonal antibodies (mAb) like risankizumab t...

    A. Michelucci, F. Manzo Margiotta, A. Cartocci in Archives of Dermatological Research (2024)